Look Up > Drugs > Erythrityl Tetranitrate
Erythrityl Tetranitrate
Pronunciation
U.S. Brand Names
Generic Available
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Drug Interactions
Mechanism of Action
Usual Dosage
Dietary Considerations
Cardiovascular Considerations
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(e RI thri til te tra NYE trate)

U.S. Brand Names
Cardilate®

Generic Available

No


Pharmacological Index

Vasodilator


Use

Prophylaxis and long-term treatment of frequent or recurrent anginal pain and reduced exercise tolerance associated with angina pectoris


Pregnancy Risk Factor

C


Contraindications

Hypersensitivity to erythrityl tetranitrate or any component; severe anemia; angle-closure glaucoma; postural hypotension; cerebral hemorrhage; head trauma


Warnings/Precautions

Use with caution in patients with hypertrophic cardiomyopathy, in patients with glaucoma, or volume depletion; tolerance may develop


Adverse Reactions

>10%: Central nervous system: Headache

1% to 10%: Cardiovascular: Tachycardia, hypotension, flushing

<1% (Limited to important or life-threatening symptoms): Restlessness, dizziness, nausea, vomiting, diarrhea, methemoglobinemia, weakness


Drug Interactions

Sildenafil: Significant reduction of systolic and diastolic blood pressure with concurrent use. Do not give sildenafil within 24 hours of a nitrate preparation.


Mechanism of Action

Erythrityl tetranitrate, like other organic nitrates, induces vasodilation by dephosphorylation of the myosin light chain in smooth muscles. This is accomplished by activation of guanylate cyclase, which eventually stimulates a cyclic GMP-dependent protein kinase that alters the phosphorylation of the myosin. Venodilation causes peripheral blood pooling, which decreases venous return to the heart, central venous pressure, and pulmonary capillary wedge pressure. A reduction in pulmonary vascular resistance occurs secondary to pulmonary arteriolar dilation and afterload may be decreased by a lowering of systemic arterial pressure.


Usual Dosage

Adults: Oral: 5 mg under the tongue or in the buccal pouch 3 times/day or 10 mg before meals or food, chewed 3 times/day, increasing in 2-3 days if needed. Dosages of up to 100 mg/day are tolerated. Some patients may need bedtime doses if they experience nocturnal symptoms.


Dietary Considerations

Should be administered before meals


Cardiovascular Considerations

Concomitant use of sildenafil (Viagra®) may precipitate acute hypotension, myocardial infarction, or death. Nitrates used in right ventricular infarction may induce acute hypotension. Nitrate use in severe pericardial effusion may reduce cardiac filling pressure and precipitate cardiac tamponade.


Mental Health: Effects on Mental Status

May cause restlessness or dizziness


Mental Health: Effects on Psychiatric Treatment

Hypotensive effects may be exacerbated by low potency antipsychotic (chlorpromazine) and TCAs


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Do not change brands without consulting physician or pharmacist; notify physician if persistent headache, dizziness, or flushing occurs; seek medical help if chest pain is unresolved after 15 minutes; do not chew or swallow sublingual tablet


Nursing Implications

Do not crush sublingual drug product

Monitor blood pressure reduction for maximal effect and orthostatic hypotension


Dosage Forms

Tablet, oral or sublingual: 10 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved